SPDR S&P Biotech ETF (NYSEARCA:XBI) Stake Boosted by Means Investment CO. Inc.

Means Investment CO. Inc. lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.4% during the third quarter, HoldingsChannel reports. The fund owned 105,366 shares of the exchange traded fund’s stock after purchasing an additional 424 shares during the quarter. SPDR S&P Biotech ETF comprises approximately 1.2% of Means Investment CO. Inc.’s holdings, making the stock its 18th biggest position. Means Investment CO. Inc.’s holdings in SPDR S&P Biotech ETF were worth $10,410,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. ORG Partners LLC acquired a new stake in SPDR S&P Biotech ETF in the second quarter valued at approximately $40,000. ORG Wealth Partners LLC bought a new stake in SPDR S&P Biotech ETF in the third quarter worth $44,000. Resources Management Corp CT ADV boosted its holdings in SPDR S&P Biotech ETF by 30.3% in the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after purchasing an additional 138 shares in the last quarter. Lynx Investment Advisory acquired a new position in SPDR S&P Biotech ETF during the second quarter worth $58,000. Finally, GPS Wealth Strategies Group LLC raised its holdings in SPDR S&P Biotech ETF by 35.9% during the second quarter. GPS Wealth Strategies Group LLC now owns 674 shares of the exchange traded fund’s stock valued at $63,000 after buying an additional 178 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

XBI opened at $99.83 on Friday. The company has a market cap of $7.61 billion, a PE ratio of 11.47 and a beta of 1.11. The stock has a 50-day moving average of $99.08 and a 200-day moving average of $94.37. SPDR S&P Biotech ETF has a 52-week low of $63.80 and a 52-week high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.